Prescription drug · ANDA
Rifampin NDC 42806-799
Rifampin 300 mg/1 · Capsule · Oral · EPIC PHARMA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42806-799-01 | 4280607990142806079901 | 100 CAPSULE in 1 BOTTLE (42806-799-01)Marketed from Dec 15, 2021 | |
| 42806-799-05 | 4280607990542806079905 | 500 CAPSULE in 1 BOTTLE (42806-799-05)Marketed from Dec 15, 2021 | |
| 42806-799-30 | 4280607993042806079930 | 30 CAPSULE in 1 BOTTLE (42806-799-30)Marketed from Dec 15, 2021 | |
| 42806-799-60 | 4280607996042806079960 | 60 CAPSULE in 1 BOTTLE (42806-799-60)Marketed from Dec 15, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rifampin
- Generic name (nonproprietary)
- rifampin
- Active ingredients
- Rifampin — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- EPIC PHARMA, LLCNDC labeler code 42806
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 064150
- Marketing start
- Listing expires
- Other FDA classes
- Rifamycins (Chemical structure)
- Identifiers
- Product ID 42806-799_a4ac02e8-68ac-4e79-8ca5-0939dd002c87SPL ID a4ac02e8-68ac-4e79-8ca5-0939dd002c87SPL set ID 0391f1e1-70d4-4b15-8b58-055bb6a385b8RxCUI 198201, 198202UNII VJT6J7R4TRUPC 0342806801307, 0342806799017
- Pharmacologic class
- Rifamycin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442806079901followed by a unit qualifier and the quantityPackage 42806-0799-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regim…
Excerpt only. Read the full label for complete information.
About NDC 42806-799
- What is NDC 42806-799?
- 42806-799 is the product NDC for Rifampin, Rifampin 300 mg/1 capsule, listed with the FDA by EPIC PHARMA, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Rifampin.
- What is the active ingredient?
- Rifampin.
- Who is the labeler?
- EPIC PHARMA, LLC, NDC labeler code 42806. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Rifampin?
- 18 other product NDCs are listed under this name. See all Rifampin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Rifampin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | ANI Pharmaceuticals, Inc. | 70954-892 | 70954-0892-1070954-0892-20 |
| Rifampin | Rifampin 300 mg/1 | CapsuleOral | ANI Pharmaceuticals, Inc. | 70954-893 | 70954-0893-1070954-0893-2070954-0893-30 |
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | Coupler LLC | 67046-1605 | 67046-1605-03 |
| rifampin | Rifampin 300 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7315 | 00904-7315-61 |
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-801 | 24658-0801-30 |
| Rifampin | Rifampin 300 mg/1 | CapsuleOral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-802 | 24658-0802-60 |
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | EPIC PHARMA, LLC | 42806-801 | 42806-0801-0142806-0801-30 |
| Rifampin | Rifampin 300 mg/1 | CapsuleOral | American Health Packaging | 60687-586 | 60687-0586-01 |
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | American Health Packaging | 60687-575 | 60687-0575-21 |
| Rifampin | Rifampin 600 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9230 | 00143-9230-01 |
Other NDCs under ANDA 064150
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | EPIC PHARMA, LLC | 42806-801 |
| Rifampin | Rifampin 300 mg/1 | CapsuleOral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-802 |
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-801 |
| Rifampin | Rifampin 150 mg/1 | CapsuleOral | Coupler LLC | 67046-1605 |